Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001193125-25-223665

Chief Operating Officer sold 6,892 shares at $8.94 ($61,630)

  • Chief Operating Officer acquired 48,900 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FORD KATHLEEN · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-27 Grant or award : show line 1 in the form 10b5-1 −48,900 70,267 D
2025-09-29 Sale : show line 2 in the form 10b5-1 −6,892 $8.94 $61,630 63,375 D
Open-market sales · 6,892 sh · avg $8.94 · $61,630
Loading xslF345X05/ownership.xml…